edaravone has been researched along with Choroid Neovascularization in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Edaravone was administered either intraperitoneally twice a day for 2 weeks or intravenously just once after laser photocoagulation." | 1.43 | Edaravone is a free radical scavenger that protects against laser-induced choroidal neovascularization in mice and common marmosets. ( Hara, H; Masuda, T; Nakamura, S; Shimazawa, M; Takata, S; Tsuruma, K, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Masuda, T | 1 |
| Shimazawa, M | 1 |
| Takata, S | 1 |
| Nakamura, S | 1 |
| Tsuruma, K | 1 |
| Hara, H | 1 |
1 other study available for edaravone and Choroid Neovascularization
| Article | Year |
|---|---|
Edaravone is a free radical scavenger that protects against laser-induced choroidal neovascularization in mice and common marmosets.
Topics: Animals; Antipyrine; Callithrix; Cell Proliferation; Cells, Cultured; Choroid; Choroidal Neovascular | 2016 |